Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
The classification of Drugs for Sinusitis includes Antibiotics, Corticosteroids, Decongestants and other. And the revenue proportion of Corticosteroids in 2015 is nearly 31%.
Drugs for Sinusitis are widely used in Neurology, Orthopedics, Musculoskeletal &Spine, Cardiology & Vascular, Skin & Integumentary, and other field ...
Table of Contents
2019-2024 Global Drugs for Sinusitis Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Sinusitis Consumption 2014-2024
2.1.2 Drugs for Sinusitis Consumption CAGR by Region
2.2 Drugs for Sinusitis Segment by Type
2.3 Drugs for Sinusitis Consumption by Type
2.3.1 Global Drugs for Sinusitis Consumption Market Share by Type (2014-2019)
2.3.2 Global Drugs for Sinusitis Revenue and Market Share by Type (2014-2019)
2.3.3 Global Drugs for Sinusitis Sale Price by Type (2014-2019)
2.4 Drugs for Sinusitis Segment by Application
2.4.1 Acute Sinusitis
2.4.2 Chronic Sinusitis
2.5 Drugs ...